Shares of International Business Machines (IBM 25.37%) plunged on Tuesday after the tech giant warned of a projected profit shortfall.
Image source: The Motley Fool.
IBM's clients are shifting their tech spending to AI-related investments IBM expects its second-quarter revenue to grow by just 1% to $17.2 billion, with earnings per share down 2% to $2.27.
Both figures were below Wall Street's estimates, which had called for revenue of nearly $17.9 billion and earnings of $3.01 per share.
Today's Change
(
-25.37
%) $
-73.65
Current Price
$
216.59
In a letter to shareholders, CEO Arvind Krishna said that IBM's customers were spending more on servers, storage, and memory to lock in supply before providers raised prices. As a result, they spent less on IBM's software and infrastructure offerings.
Additionally, companies prioritized cybersecurity investments to counter new artificial intelligence (AI)-powered threats. In turn, they delayed other, non-cybersecurity deals with IBM.
"These are not excuses, but they are realities," Krishna said.
As risks rise, IBM's share price falls Prior to today, many investors thought IBM had done enough to position itself as a beneficiary of the AI boom. Krishna's warnings, however, call those beliefs into question.
Shareholders are now forced to price in the potential disruption that AI-related spending can have on IBM's revenue streams, and its stock price is down sharply as a result.
Investors will want to tune into IBM's second-quarter earnings call on July 22 at 5 p.m. ET, during which Krishna will lay out his plan to adapt to these AI-driven trends.
Joe Tenebruso has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends International Business Machines. The Motley Fool has a disclosure policy.
Stock market players were clearly uninterested in pursuing a relationship with customer relationship management (CRM) software king Salesforce (CRM 2.13%) on Tuesday. The veteran company's shares slid by more than 2% that trading session, as they were swept up in a broader rout of long-standing software companies.
Softness in software This general bearishness can't be blamed directly on Salesforce. Rather, it can be tracked to the latest news from software titan International Business Machines. That company issued a preliminary quarterly earnings report Tuesday morning; both it and its shareholders probably now wish it hadn't.
Image source: Getty Images.
That's because IBM's projections for revenue and profitability indicate both relatively weak growth and a pair of misses of analyst estimates. For the record, it's expecting only a 1% year-over-year bump in revenue to slightly over $17 billion, and a 5% rise in net income not under generally accepted accounting principles (GAAP) to $2.27 per share.
What made this really sting and helped ignite that software segment rout was IBM CEO Arvind Krishna's reasoning for the weaker-than-expected figures. Krishna spoke of notable shifts among clients in their technology spending, from software to hardware items such as servers and storage.
That's hardly surprising, given the anticipated price increases due to supply constraints "thanks" to the intense build-out of artificial intelligence (AI) technology.
Today's Change
(
-2.13
%) $
-3.64
Current Price
$
167.58
A potentially strong headwind While this is understandable, it isn't very comforting to investors in software stocks -- even those who have demonstrated long-term strength, like Salesforce. As bearish for the segment as it is, Krishna's take on the current customer trend feels accurate and realistic.
As it's hard to predict when those looming price increases might subside -- or even if they do, in the most extreme case -- I'd tread lightly around software stocks these days. I've always liked Salesforce as a business, but the trend just isn't its friend at the moment.
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends International Business Machines and Salesforce. The Motley Fool has a disclosure policy.
As the second-quarter earnings season heats up, investors are looking for companies that combine durable long-term growth drivers with strong underlying fundamentals.
While quarterly reports can create short-term volatility, they also provide opportunities to build positions in high-quality businesses that have the potential to outperform over time.
Three stocks that stand out ahead of their upcoming Q2 reports on Thursday, July 16 are GE Aerospace (GE - Free Report) ), Taiwan Semiconductor (TSM - Free Report) ), and UnitedHealth Group (UNH - Free Report) ).
Each operates in an industry with attractive long-term demand trends, boasts market-leading positions, and has catalysts that could support further upside if quarterly results reinforce their investment theses.
GE Aerospace Continues to Benefit From Aviation RecoveryGE Aerospace has emerged as one of the market's premier industrial companies following its transformation into a pure-play aerospace business. The company continues to benefit from robust commercial air travel demand following the COVID-19 pandemic, rising aircraft utilization, and a growing backlog of engine service work.
Perhaps GE's greatest strength is its highly profitable aftermarket business. As airlines keep aircraft flying longer amid ongoing delivery constraints from Boeing (BA - Free Report) ) and Airbus (EADSY - Free Report) ), demand for maintenance, repair, and overhaul services continues to rise. Since servicing engines typically generates higher margins than selling new ones, this dynamic has helped drive steady earnings expansion.
Analysts expect another quarter of solid revenue and earnings growth as commercial aviation remains healthy despite lingering supply-chain challenges. GE’s Q2 revenue is expected to be up nearly 17% to $11.86 billion, with quarterly EPS projected to rise 12% to $1.86.
Taiwan Semiconductor Remains at the Center of the AI BoomFew companies are more important to the artificial intelligence investment story than Taiwan Semiconductor. As the world's largest contract chip manufacturer, TSM produces the advanced semiconductors powering AI accelerators designed by Nvidia (NVDA - Free Report) ), AMD (AMD - Free Report) ), Broadcom (AVGO - Free Report) ), and Apple (AAPL - Free Report) ).
Demand for advanced manufacturing capacity continues to outpace supply, allowing Taiwan Semiconductor to benefit from favorable pricing, exceptional capacity utilization, and expanding profit margins.
Adding confidence ahead of earnings, the company most recently reported record quarterly revenue and EPS during Q1 at $35.89 billion and $3.49 per share, respectively.
Wall Street expects new quarterly peaks, with consensus estimates calling for Q2 EPS of $3.87 on nearly $40 billion in revenue, reflecting continued AI-driven demand. Those expectations reflect nearly 57% EPS growth and 32% sales growth.
UnitedHealth is Staging an Impressive TurnaroundTrading near its 52-week high, UnitedHealth Group’s stock has been on an impressive rebound after facing increased regulatory scrutiny, higher-than-expected Medicare Advantage utilization, and uncertainty surrounding reimbursement trends.
With those headwinds starting to subside, investors are starting to re-recognize the company's industry-leading scale. Although Q2 sales are expected to dip 1% to $110.05 billion, quarterly EPS is expected to be up 18% to $4.84, reflecting the health giant’s more promising execution.
Of course, what has also kept investors engaged is that UNH offers a very respectable 2.16% annual dividend yield that equates to $9.28 per share quarterly.
Bottom LineQuarterly earnings often create volatility, but they can also present opportunities to accumulate shares of industry leaders with durable competitive advantages.
GE Aerospace and Taiwan Semiconductor are currently sporting a Zacks Rank #2 (Buy), with UnitedHealth Group stock boasting a Zacks Rank #1 (Strong Buy). Investors looking to strengthen their portfolios as the Q2 earnings season heats up may find these three blue-chip companies worthy of closer consideration.
Unlike many other tech stocks, Broadcom (AVGO +1.37%) landed in positive territory on the second trading day of the week. It closed the trading session more than 1% higher, thanks to capital flight from software titles to hardware makers, and to a bullish analyst update.
The IBM Effect Tech investors were cycling out of legacy software companies following International Business Machines' release of its preliminary second-quarter results. These indicate that both the company's revenue and net profit, not under generally accepted accounting principles (GAAP), will come in well under analyst consensus estimates.
Image source: Getty Images.
The company's CEO Arvind Krishna attributed this to a broad adjustment in capital spending by clients during the period. He said they were favoring storage and memory solutions, as well as servers, over software. In his view, this trend is due to anticipated price increases in such goods.
In turn, that's being driven by supply constraints related to the massive build-out of artificial intelligence (AI) technology. Broadcom is a high-profile developer and supplier of custom AI chips and AI networking silicon.
Today's Change
(
1.37
%) $
5.27
Current Price
$
389.32
Keep buying, says analyst That was bolstered by a new note from Morgan Stanley analyst Joseph Moore. This analysis focused on the potential threat posed by fellow chipmaker MediaTek to Broadcom's business as a component supplier for Alphabet's tensor processing units (TPUs; specialized AI chips from that company's Google subsidiary).
According to reports, in concluding that MediaTek isn't a serious, disruptive threat to Broadcom's Google TPU business, he reiterated his overweight (read: buy) recommendation on Broadcom. Moore is particularly heartened by what he sees as Broadcom's ability to win new business for its custom AI chips, which should reduce any dependence on the Google partnership.
I continue to think of Broadcom as a company on the front lines of the AI revolution. And while that hardware spending might be front-loaded to beat upcoming price hikes, demand for the components that power AI -- like Broadcom's chips and components -- will remain strong. To me, the stock's price bump on Tuesday was too modest, if anything.
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet, Broadcom, and International Business Machines. The Motley Fool has a disclosure policy.
Tuesday's stock trading session was marked by a notable shift, as tech investors sold legacy software companies and moved into next-generation hardware makers and cybersecurity titles.
That, plus a new cybersecurity warning from top-level government agencies, greatly benefited cybersecurity segment mainstay Palo Alto Networks (PANW +6.94%). The company's equity rose by nearly 7% that day.
A stark warning That warning was issued by a clutch of federal government security organizations led by the Cybersecurity and Infrastructure Security Agency (CISA), and including the National Security Agency (NSA) and the Federal Bureau of Investigation (FBI). These were joined by international counterparts.
Image source: Getty Images.
The agencies cautioned that "Russian cyber threat actors are targeting vulnerable networking devices in critical infrastructure sectors globally, especially communications, defense industrial base, energy, financial services, government services and facilities, and healthcare and public health."
Among other measures, the agencies recommended that businesses and other organizations implement stronger authentication and data encryption measures and monitor suspicious activity.
Compounding that was the preliminary quarterly earnings update from software giant International Business Machines. The company revealed that its second-quarter revenue and net income not under generally accepted accounting principles (GAAP) would come in notably below the average analyst estimates.
What sent investors running to other segments of the tech sector was remarks from IBM CEO Arvind Krishna. He said IBM was seeing clients prioritize capital spending on hardware items such as servers and memory. It logically follows that if such a shift is occurring, a ramp-up in cybersecurity spend is also necessary to protect those new goods.
Today's Change
(
6.94
%) $
22.93
Current Price
$
353.23
Shock to the system Since Palo Alto Networks is a prominent company in the cybersecurity sphere, it's sure to be a go-to for many clients aiming to beef up the protection of their networks, systems, and equipment.
The danger of sudden, sharply increased spending on segments like cybersecurity is that it often corrects shortly thereafter. Palo Alto Networks is an effective and respected operator in the space, but I'd caution that any potential sales spike could lead to weak year-over-year comparisons in subsequent quarters.
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends International Business Machines. The Motley Fool recommends Palo Alto Networks. The Motley Fool has a disclosure policy.
Rithm (RITM - Free Report) closed at $9.22 in the latest trading session, marking a +1.65% move from the prior day. This move outpaced the S&P 500's daily gain of 0.38%. Elsewhere, the Dow gained 0.02%, while the tech-heavy Nasdaq added 0.9%.
Coming into today, shares of the real estate investment trust had lost 1.31% in the past month. In that same time, the Finance sector gained 2.89%, while the S&P 500 gained 1.27%.
The upcoming earnings release of Rithm will be of great interest to investors. The company is expected to report EPS of $0.5, down 7.41% from the prior-year quarter. In the meantime, our current consensus estimate forecasts the revenue to be $1.46 billion, indicating a 19.89% growth compared to the corresponding quarter of the prior year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $2.23 per share and a revenue of $6.02 billion, signifying shifts of -5.11% and +37.48%, respectively, from the last year.
Investors should also note any recent changes to analyst estimates for Rithm. Such recent modifications usually signify the changing landscape of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 1.62% lower within the past month. At present, Rithm boasts a Zacks Rank of #4 (Sell).
Investors should also note Rithm's current valuation metrics, including its Forward P/E ratio of 4.07. This denotes a discount relative to the industry average Forward P/E of 10.88.
The Financial - Miscellaneous Services industry is part of the Finance sector. This group has a Zacks Industry Rank of 171, putting it in the bottom 31% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
4:20pm: Rate hopes lift markets US stocks finished mostly higher on Tuesday after a softer-than-expected inflation report boosted hopes that the Federal Reserve may not need to raise interest rates this month.
The Nasdaq led the gains, climbing 0.9% as semiconductor stocks rallied, while the S&P 500 added 0.4%. The Dow Jones Industrial Average finished little changed, edging up just 10 points. The June Consumer Price Index fell 0.4% from the previous month, bringing the annual inflation rate down to 3.5%, below economists' expectations of 3.8%. Following the report, market expectations for a July rate hike dropped sharply, with traders pricing in just a 16% chance compared with 42% before the data. New Fed Chair Kevin Warsh also struck a measured tone in congressional testimony, saying inflation remains too high but acknowledging recent progress.
Chipmakers were among the day's biggest winners, with Micron Technology (NASDAQ: MU) and Applied Materials (NASDAQ: AMAT) each jumping more than 4% as investors welcomed the prospect of a less aggressive Fed. Financial stocks also remained in focus after strong earnings from JPMorgan Chase (NYSE: JPM) and Goldman Sachs (NYSE: GS). Not every company shared in the optimism, however. IBM tumbled 25% after issuing a disappointing preliminary second-quarter earnings update, citing weak mainframe demand and delayed software deals.
Investors now turn their attention to another busy day of earnings on Wednesday, with results due from ASML, Johnson & Johnson (NYSE:JNJ), Morgan Stanley (NYSE:MS), and BlackRock.
3:45pm: Proactive news headlines American Resources Corp (NASDAQ:AREC) said its ReElement Technologies subsidiary received a $25 million investment from the U.S. Department of War to expand its Indiana rare earth and critical mineral refining campus with new equipment, production capacity, and working capital. Nine Mile Metals Ltd. (CSE:NINE, OTCQB:VMSXF, FRA:KQ9) reported that its third drill hole of the 2026 program at the Wedge project in New Brunswick intersected 125.25 metres of pyrite and chalcopyrite mineralization, with assay results pending. Century Lithium Corp. (TSX-V:LCE, OTCQX:CYDVF) appointed independent director Corby Anderson as board chair, while former chair Bryan Disher transitioned to a non-executive role and will continue to lead the company's Audit Committee. Blockmate Ventures Inc (TSX-V:MATE, OTCQB:MATEF, FRA:8MH) closed an oversubscribed $1 million private placement, with proceeds earmarked to advance its Wyoming AI data centre project and for general working capital. Standard Uranium Ltd (TSX-V:STND, OTCQB:STTDF, FRA:9SU0) reported encouraging geochemical results from its winter 2026 drill program at the Corvo uranium project in Saskatchewan, identifying anomalous uranium and pathfinder elements that support further exploration. 2:40pm: Market movers International Business Machines Corp (NYSE:IBM) shares fell sharply after preliminary second-quarter results missed expectations, with the company warning that weaker-than-expected customer spending hurt its software and infrastructure businesses. Bel Fuse (NASDAQ:BELFB) was initiated with a Buy rating and a $330 price target by Bank of America, which cited the company’s improved profitability, portfolio optimization, pricing gains, cost discipline, and growth in higher-margin markets such as aerospace, defense, space, and data infrastructure. Uber Technologies Inc (NYSE:UBER, XETRA:UT8) and Delivery Hero (XETRA:DHER, OTCQX:DLVHF) (Delivery Hero (XETRA:DHER, OTCQX:DLVHF), Delivery Hero (XETRA:DHER, OTCQX:DLVHF)) are reportedly in advanced talks for Uber to acquire the German food-delivery company, with a potential agreement expected soon as Delivery Hero (XETRA:DHER, OTCQX:DLVHF) shares climbed while Uber shares declined. American Resources Corp (NASDAQ:AREC) said its ReElement Technologies subsidiary received a $25 million U.S. Department of War investment to expand its Indiana rare earth and critical mineral refining campus with new equipment, production capacity, and working capital. CleanSpark Inc (NASDAQ:CLSK) announced a 20-year lease agreement for its Sandersville, Georgia data center campus with a global technology company, a deal expected to generate about $6.6 billion in contracted revenue and potentially $11.6 billion with extensions. Nine Mile Metals Ltd. (CSE:NINE, OTCQB:VMSXF, FRA:KQ9) reported that its latest drill hole at the Wedge project in New Brunswick intersected 125 metres of sulphide mineralization containing pyrite and chalcopyrite, with assay results still pending. Tower Semiconductor (NASDAQ:TSEM) shares jumped after the company announced a Japan-backed expansion of its silicon photonics, silicon germanium, and advanced packaging capabilities to meet growing demand from AI and data center customers. Bank of America Corp (NYSE:BAC) shares rose after the bank posted second-quarter results above Wall Street forecasts, driven by growth in net interest income, investment banking, trading, and wealth management. Citigroup Inc (NYSE:C) reported second-quarter revenue that exceeded estimates, supported by strength in fixed-income trading and investment banking, with earnings per share reaching $3.15. Goldman Sachs Group Inc (NYSE:GS, XETRA:GOS) shares gained after the investment bank delivered stronger-than-expected second-quarter results, helped by solid investment banking and trading performance. 1:10pm: Uber eyeing Delivery Hero (XETRA:DHER, OTCQX:DLVHF) Uber Technologies Inc (NYSE:UBER, XETRA:UT8) (Uber Technologies Inc (NYSE:UBER, XETRA:UT8), Uber Technologies Inc (NYSE:UBER, XETRA:UT8)) is in advanced talks to acquire German food-delivery company Delivery Hero (XETRA:DHER, OTCQX:DLVHF) (Delivery Hero (XETRA:DHER, OTCQX:DLVHF), Delivery Hero (XETRA:DHER, OTCQX:DLVHF)), according to a Bloomberg report, with the companies aiming to finalize a takeover agreement as soon as this week.
Shares of Delivery Hero (Delivery Hero (XETRA:DHER, OTCQX:DLVHF), Delivery Hero (XETRA:DHER, OTCQX:DLVHF)) rose almost 6% following the report, while Uber shares fell about 2%.
Uber has already built a significant stake in Delivery Hero, holding 24.99% of the company’s shares and additional derivatives that bring its total economic interest to about 36.8%.
The reported acquisition discussions follow months of stake-building by Uber as the company seeks to expand its position in the global food-delivery market. A full takeover would give Uber control of one of Europe’s largest online food-delivery platforms.
12:00pm: 'Benign' inflation print LPL Financial chief economist Jeffrey Roach said June's cooler-than-expected inflation report was largely driven by a sharp drop in energy prices, which pushed the annual headline CPI rate down to 3.5%. However, he cautioned that the decline may prove temporary, as energy prices have risen in early July.
Roach noted that core inflation slowed to 2.59% year over year, its lowest level since February, and expects it to ease further through the third and fourth quarters as durable goods prices improve. He said the report is supportive for investor sentiment but warned that geopolitical risks remain the biggest wildcard, adding that inflation should improve more meaningfully by year-end if supply chains normalize by Labor Day.
"After today’s benign core inflation release, it appears less likely that the FOMC will raise rates over the next few meetings," Roach wrote.
"However, we may still be at an inflection point, given the risk that the energy shock could spill over into other categories of consumer prices. A positive resolution with Iran before the end of the summer is becoming increasingly important."
10:45am: Soft CPI eases pressure Bank of America said the softer-than-expected reading eases near-term pressure on the Federal Reserve to raise interest rates, while also pointing to further evidence that tariff-driven price pressures are fading as goods prices broadly declined.
The bank noted there was little sign of World Cup-related inflation, while softer rent data suggests recent strength in housing inflation may have been temporary.
Even so, it maintained its forecast for 75 basis points of rate hikes this year beginning in September, saying the weak CPI report gives the Fed "the luxury of staying on hold a little longer" even as inflation remains above its target.
10am: Chipmakers and banks help Wall Street open higher US stocks have opened higher, led by the Nasdaq's chipmakers and semiconductor equipment stocks, with big banks gaining too after earnings.
The tech-heavy index rose 0.5%, ahead of gains of around 0.2% for both the S&P 500 and Dow Jones.
Strongest performers included Lumentum, Lam Research, AMD, Marvell, Micron, Applied Materials and Intel.
The Dow was held back by a 24% plunge for IBM, with the next fallers being Salesforce, down 3.4% and Microsoft, down 2%.
Goldman Sachs was close to the top of the S&P leaderboard, up 5.1% on the back of a strong set of earnings, with JPMorgan Chase also crushing it.
8.40am: CPI gives boost Stock futures have picked up after a softer-than-expected CPI report boosted hopes the Federal Reserve will keep interest rates on hold.
June's CPI rate eased to 3.5% from 4.2%, below forecasts of 3.8%, while core inflation eased to 2.6% against expectations of 2.8%.
On a monthly basis, CPI fell 0.4% compared to May, the biggest monthly decline since May 2020, prompting traders to pare bets on Fed hikes.
S&P 500 futures are now up 0.4% and Nasdaq futures 0.7% higher, while Dow futures are down 0.1%.
8am: Mixed open expected, IBM set to plunge Wall Street looked set for a mixed open as investors digested a 23% plunge in IBM shares, another jump in oil prices and the start of the second-quarter earnings season.
Dow Jones futures were down 281 points, or 0.5%, while S&P 500 futures were 0.1% lower. Nasdaq futures were pointing higher, up 0.6% after a sell-off in technology stocks at the start of the week.
Yesterday saw the Nasdaq tumble 1.6% to 25,873 as higher oil prices and weakness in chipmakers weighed on sentiment, with the S&P 500 dropping 0.8% to 7,515 and the Dow slipping 0.3% to 52,499 .
On Tuesday morning, US benchmark WTI crude is up 2% at $79.60 a barrel, having topped $81 earlier.
This escalation follows a third consecutive night of US strikes on Iran and after President Donald Trump announced a renewed blockade of Iranian shipping and proposed a 20% fee on Iranian cargo passing through the Strait of Hormuz.
Iran rejected the move, while the UAE said Iranian missiles had struck two oil tankers transiting the waterway.
Attention now turns to June's US inflation report, which could shape expectations for interest rates, before earnings season begins in earnest.
JPMorgan Chase, Bank of America, Goldman Sachs, Wells Fargo and Citigroup kick off the US bank earnings season before the opening bell.
IBM shares plunged more than 23% in premarket trading after the technology group's preliminary second-quarter results showed revenue growth slowed to 1%, with a 7% decline in infrastructure sales offsetting gains in software.
The company reported revenue of $17.2 billion, while operating earnings per share rose 5% to $2.93 and year-to-date free cash flow reached $4.8 billion, but investors focused on the weaker top-line performance and pressure on margins.
Zoetis (ZTS - Free Report) closed the most recent trading day at $74.07, moving -1.75% from the previous trading session. The stock's performance was behind the S&P 500's daily gain of 0.38%. Meanwhile, the Dow experienced a rise of 0.02%, and the technology-dominated Nasdaq saw an increase of 0.9%.
Heading into today, shares of the animal health company had lost 5.7% over the past month, lagging the Medical sector's gain of 4.34% and the S&P 500's gain of 1.27%.
Investors will be eagerly watching for the performance of Zoetis in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on August 6, 2026. In that report, analysts expect Zoetis to post earnings of $1.85 per share. This would mark year-over-year growth of 5.11%. At the same time, our most recent consensus estimate is projecting a revenue of $2.49 billion, reflecting a 1.42% rise from the equivalent quarter last year.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $6.89 per share and a revenue of $9.72 billion, representing changes of +7.49% and +2.69%, respectively, from the prior year.
It is also important to note the recent changes to analyst estimates for Zoetis. These revisions typically reflect the latest short-term business trends, which can change frequently. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.01% downward. Zoetis currently has a Zacks Rank of #4 (Sell).
Looking at valuation, Zoetis is presently trading at a Forward P/E ratio of 10.94. This indicates a discount in contrast to its industry's Forward P/E of 17.15.
Meanwhile, ZTS's PEG ratio is currently 1.17. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The average PEG ratio for the Medical - Drugs industry stood at 1.74 at the close of the market yesterday.
The Medical - Drugs industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 164, positioning it in the bottom 34% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
The Writers Guild of America became the latest group to challenge Paramount’s $81 billion acquisition of Warner Bros. Discovery on Tuesday, filing a lawsuit that seeks to block the merger on the grounds it would cause “specific harm” to movie and TV writers working across the U.S.
A Paramount-Warner merger “threatens the economic and creative health of the American entertainment industry,” reads Tuesday’s federal complaint, which was filed by both the Writers Guild of America West and Writers Guild of America East (jointly the WGA).
The union argued that the merger would create less competitors and give the larger company “both the incentive and the ability” to lower wages and the number of projects that offer workers employment.
The Warner Bros. Water Tower is pictured at Warner Bros. Studios in Burbank on the day it was announced that California and 11 states are suing to block Paramount’s $110 billion acquisition of Warner Bros. Discovery in California, U.S. July 13, 2026. REUTERS “This proposed combined entity would be the largest employer of writers, with tremendous power to suppress our wages, eliminate opportunities for emerging writers, cut jobs across the industry, and produce less programming,” WGAE President Tom Fontana said in a statement.
A Warner-Paramount tie-up would bring together two of the five last legacy studios in Hollywood. It would also mean putting Warner’s HBO Max, its libraries filled with popular titles like “Harry Potter” and even CNN under the same roof of Paramount-owned CBS, movies like “Top Gun” and the Paramount+ streaming service.
Tuesday’s complaint alleges that the merger violates antitrust law by reducing competition in three markets for writers: writing for episodic TV and streaming series, TV writing deals overall and screenwriting for the biggest theatrical films.
In response, Skydance-owned Paramount maintained that a combined Warner-Paramount would allow the company to “expand opportunities for writers, not shrink them.” It also reiterated pledges to release at least 30 movies a year with a 45-day window exclusive to theaters — and said it would continue to commission from independent production companies while maintaining “two distinct film studios.”
“A stronger Hollywood only means something if it’s stronger for the writers who power it,” the company said in a statement.
The WGA’s complaint arrives a day after 12 states, led by California Attorney General Rob Bonta, filed a lawsuit challenging the deal, alleging that it would “extinguish competition” in Hollywood and lead to fewer choices for moviegoers and cable TV customers nationwide.
In an aerial view, othe Paramount logo is displayed on a water tower at the Paramount Studios lot on July 13, 2026 in Los Angeles, California. Getty Images The coalition of states called on Warner and Paramount to not close the merger until after a court had time to “fully evaluate” their claims. But they said the companies quickly refused — and late Monday night, the group filed an emergency motion in federal court seeking a temporary restraining order and preliminary injunction aimed at immediately halting the deal.
Paramount on Monday called the states’ claims “wrong on both the facts and the law” and vowed to “vigorously defend” its Warner acquisition.
The growing list of legal challenges could become a roadblock in Paramount’s quest to complete its purchase of Warner. Other regulatory reviews are ongoing in the European Union and in the U.K., which has suggested it may intervene. But Paramount has also racked up effective green lights from a handful of other countries, including the Trump administration in the U.S., China, Canada and Australia.
Paramount and Warner have hoped to close their deal sometime in the third quarter of this year. In Monday night’s motion seeking an immediate pause, the states said the companies may try to complete the process as early as July 22.
Including debt, Paramount’s proposed purchase of Warner is valued at nearly $111 billion based on outstanding shares.
Currently trading for around $18 per share, Rivian Automotive (RIVN +1.21%) has fallen by 82.5% since its 2021 initial public offering (IPO).
Most longtime Rivian investors remain underwater, but new investors could profit following the recent launch of the EV maker's lower-priced R2 line. That said, while the R2 may revive growth, it may not move the needle for the stock.
Image source: Getty Images.
How the R2 could get Rivian out of its slump When Rivian first went public, investors were willing to pay high premiums for would-be "Tesla killers" that could challenge the EV market leader. However, as results clashed with expectations, the prices of Rivian and other electric car stocks cratered.
Today's Change
(
1.21
%) $
0.21
Current Price
$
17.52
More recently, however, Rivian has held fairly steady amid the hype surrounding the launch of the R2 vehicle. Priced much lower than Rivian's initial R1S and R1T models, this new line could represent an inflection point. Recent results and outlook updates support this view.
Big potential, but there's a caveat Last quarter, Rivian reported 12,194 vehicle deliveries, well ahead of prior guidance. A big reason for this was June's launch of the R2 SUV, with a sticker price of $57,990.
In addition, management increased its full-year production guidance, raising the ceiling from 67,000 to 70,000 vehicles. In the years ahead, high growth could persist. Yet while forecasts call for growth to accelerate from 34.2% this year to 61.6% in 2027, they also call for annual losses of $2.61 and $2.28 per share, respectively.
Also, Rivian plans to fund expansion through dilutive share sales, aiming to raise up to $8 billion through 2028. Compared to Rivian's current $25 billion market cap, this level of dilution could really water down gains, even if profitability arrives sooner than expected. Hence, it may be a while before a surge in production growth leads to big gains for Rivian shares.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Zscaler (ZS) To Contact Him Directly To Discuss Their Options
If you purchased or acquired stock in Zscaler and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at [email protected] or by telephone at (212) 355-4648.
Click here to participate in the action.
NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) --
What’s Happening:
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Zscaler, Inc. (“Zscaler” or the “Company”) (NASDAQ:ZS) on behalf of Zscaler stockholders. Our investigation concerns whether Zscaler has violated the federal securities laws and/or engaged in other unlawful business practices. Investigation Details:
On May 27, 2026, the Company issued weaker-than-expected guidance and disclosed disruptions tied to sales leadership changes, despite reporting quarterly results that exceeded analyst expectations. Reports indicated that investors were concerned about slowing growth projections, weaker customer expansion, and uncertainty surrounding the Company's sales execution and outlook. Following this news, Zscaler's stock suffered its steepest single-day decline since going public.
On this news, Zscaler's stock price fell $58.19, or 31.52% to close at $126.41 per share on May 27, 2026. Next Steps:
If you purchased or otherwise acquired Zscaler shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at [email protected], by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in securities, derivative, and commercial litigation as well as individuals in consumer protection and data privacy litigation. The firm has a nationwide practice and routinely handles cases in both federal and state courts. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Follow us for updates on LinkedIn and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn.
Dick's Sporting Goods (DKS - Free Report) closed at $211.37 in the latest trading session, marking a -2.19% move from the prior day. The stock's change was less than the S&P 500's daily gain of 0.38%. Elsewhere, the Dow saw an upswing of 0.02%, while the tech-heavy Nasdaq appreciated by 0.9%.
Heading into today, shares of the sporting goods retailer had lost 1.79% over the past month, lagging the Retail-Wholesale sector's gain of 0.77% and the S&P 500's gain of 1.27%.
Analysts and investors alike will be keeping a close eye on the performance of Dick's Sporting Goods in its upcoming earnings disclosure. The company's upcoming EPS is projected at $3.8, signifying a 13.24% drop compared to the same quarter of the previous year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $5.64 billion, up 54.57% from the year-ago period.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $14.24 per share and a revenue of $22.38 billion, indicating changes of +7.88% and +29.99%, respectively, from the former year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Dick's Sporting Goods. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.04% higher. Dick's Sporting Goods is currently sporting a Zacks Rank of #3 (Hold).
In terms of valuation, Dick's Sporting Goods is currently trading at a Forward P/E ratio of 15.18. This indicates a premium in contrast to its industry's Forward P/E of 14.74.
One should further note that DKS currently holds a PEG ratio of 1.89. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Retail - Miscellaneous industry currently had an average PEG ratio of 1.89 as of yesterday's close.
The Retail - Miscellaneous industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 78, which puts it in the top 32% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
Interactive Brokers Group, Inc. (IBKR - Free Report) closed the most recent trading day at $95.61, moving +2.19% from the previous trading session. This change outpaced the S&P 500's 0.38% gain on the day. Elsewhere, the Dow saw an upswing of 0.02%, while the tech-heavy Nasdaq appreciated by 0.9%.
Shares of the company witnessed a gain of 0.86% over the previous month, trailing the performance of the Finance sector with its gain of 2.89%, and the S&P 500's gain of 1.27%.
Investors will be eagerly watching for the performance of Interactive Brokers Group, Inc. in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on July 21, 2026. The company's earnings per share (EPS) are projected to be $0.59, reflecting a 15.69% increase from the same quarter last year. In the meantime, our current consensus estimate forecasts the revenue to be $1.66 billion, indicating a 12.16% growth compared to the corresponding quarter of the prior year.
IBKR's full-year Zacks Consensus Estimates are calling for earnings of $2.51 per share and revenue of $6.9 billion. These results would represent year-over-year changes of +14.61% and +12.14%, respectively.
Investors might also notice recent changes to analyst estimates for Interactive Brokers Group, Inc. These revisions help to show the ever-changing nature of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 2.17% higher within the past month. Interactive Brokers Group, Inc. presently features a Zacks Rank of #2 (Buy).
Looking at valuation, Interactive Brokers Group, Inc. is presently trading at a Forward P/E ratio of 37.28. For comparison, its industry has an average Forward P/E of 14.37, which means Interactive Brokers Group, Inc. is trading at a premium to the group.
We can additionally observe that IBKR currently boasts a PEG ratio of 2.53. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Financial - Investment Bank industry currently had an average PEG ratio of 1.05 as of yesterday's close.
The Financial - Investment Bank industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 70, placing it within the top 29% of over 250 industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
In the latest close session, McKesson (MCK - Free Report) was down 1.1% at $803.37. This move lagged the S&P 500's daily gain of 0.38%. At the same time, the Dow added 0.02%, and the tech-heavy Nasdaq gained 0.9%.
Heading into today, shares of the prescription drug distributor had gained 4.17% over the past month, lagging the Medical sector's gain of 4.34% and outpacing the S&P 500's gain of 1.27%.
The investment community will be closely monitoring the performance of McKesson in its forthcoming earnings report. The company is scheduled to release its earnings on August 5, 2026. In that report, analysts expect McKesson to post earnings of $9.59 per share. This would mark year-over-year growth of 16.1%. Alongside, our most recent consensus estimate is anticipating revenue of $104.39 billion, indicating a 6.7% upward movement from the same quarter last year.
For the full year, the Zacks Consensus Estimates project earnings of $44.28 per share and a revenue of $432.77 billion, demonstrating changes of +13.22% and +7.27%, respectively, from the preceding year.
It is also important to note the recent changes to analyst estimates for McKesson. Such recent modifications usually signify the changing landscape of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0% higher. Currently, McKesson is carrying a Zacks Rank of #2 (Buy).
Looking at its valuation, McKesson is holding a Forward P/E ratio of 18.34. This valuation marks a premium compared to its industry average Forward P/E of 17.08.
It's also important to note that MCK currently trades at a PEG ratio of 1.34. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. MCK's industry had an average PEG ratio of 1.86 as of yesterday's close.
The Medical - Dental Supplies industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 64, positioning it in the top 27% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?Aehr Test Systems NASDAQ: AEHR said it entered fiscal 2027 with record backlog and expects revenue to more than double, citing accelerating demand tied to artificial intelligence processors, silicon photonics and data center infrastructure.
President and Chief Executive Officer Gayn Erickson said the company’s fiscal fourth quarter “exceeded consensus street expectations” and capped a year in which Aehr broadened its business beyond its earlier concentration in silicon carbide devices for electric vehicles.
Get Aehr Test Systems alerts:
MarketBeat Week in Review – 04/20 - 04/24“Just two years ago, over 95% of our business was tied to silicon carbide for electric vehicles, whereas today, almost 95% of our fiscal year 2026 revenue came from markets not electric vehicle silicon carbide,” Erickson said.
The company issued fiscal 2027 revenue guidance of $130 million to $150 million, which Chief Financial Officer Chris Siu said would represent year-over-year growth of about 160% to 200%. Aehr also expects non-GAAP pretax net income to be 18% to 22% of total revenue.
AI and Data Center Demand Drive Outlook Aehr Test Systems: Small AI Stock Sees Record AI Hyperscaler OrderAehr reported fiscal fourth-quarter bookings of $60.7 million, up more than 500% from $11.1 million in the prior-year quarter. Year-end backlog reached a record $80.6 million, compared with $15.2 million at the end of fiscal 2025. Siu said the company received an additional $20 million in bookings after year-end during a transition period and the first two weeks of fiscal 2027, bringing “effective backlog” to approximately $100.6 million before minimal shipments in that period.
Management attributed the bookings increase primarily to purchase orders for Sonoma package-level and FOX wafer-level burn-in systems, WaferPaks and burn-in module boards for AI and silicon photonics processor burn-in. Those gains were partially offset by lower customer orders for silicon carbide WaferPaks.
Erickson said reliability and production wafer-level burn-in and screening for AI accelerators, CPUs and network processors were Aehr’s fastest-growing markets in fiscal 2026, representing about 71% of annual revenue. Optical device test and burn-in for data center infrastructure transceivers, chip-to-chip I/O and hard disk drives accounted for another 20%.
In the fourth quarter, AI processors and silicon photonics burn-in accounted for more than 80% of revenue, compared with 56% in the prior-year period. Siu said Aehr had three customers representing more than 10% of total quarterly revenue: two targeting the AI market and one focused on data center optical transceivers.
Fourth-Quarter Revenue Rises; Full-Year Revenue Declines Fourth-quarter revenue totaled $18.8 million, up 34% from $14.1 million in the same quarter a year earlier. Siu said the increase was primarily driven by strong demand from AI and data center customers for FOX systems, Zero Auto Aligners and WaferPaks.
Non-GAAP gross margin in the fourth quarter was 45%, up from 35% a year earlier, which Siu attributed to higher revenue levels, improved manufacturing capacity utilization and a more favorable product mix. Non-GAAP operating expenses rose to $7.5 million from $5.4 million, reflecting higher employment costs, additional headcount for research and development projects, higher commissions tied to record bookings and ongoing legal fees related to patent litigation against SemiE in China.
Non-GAAP net income for the quarter was $3.6 million, or $0.11 per diluted share, compared with a non-GAAP net loss of $0.2 million, or $0.01 per diluted share, in the fourth quarter of fiscal 2025.
For the full year, Aehr reported revenue of $50 million, down 15% from fiscal 2025. Full-year non-GAAP gross margin was 38.5%, compared with 44% a year earlier. Non-GAAP net income was $0.9 million, or $0.03 per diluted share, compared with $4.6 million, or $0.15 per diluted share, in fiscal 2025.
Cash, cash equivalents and restricted cash totaled $116.5 million at the end of the fourth quarter. Siu said Aehr raised approximately $100 million during fiscal 2026, primarily through its at-the-market program, while capital expenditures were $2.1 million.
Wafer-Level and Package-Level Platforms Expand Erickson said Aehr’s lead AI processor wafer-level burn-in customer doubled its systems from the company over the past year and moved “all production burn and screening to wafer-level burn-in” on Aehr systems. He said that customer is forecasting significant increases in wafer allocation from its foundry this year and beyond.
Aehr also said it completed benchmark testing of its wafer-level burn-in solution with a major supplier of AI accelerators, CPUs and network processors. Erickson said the results exceeded the customer’s expectations and were described by the customer as “better than they can get at package level.” The customer has expressed interest in moving to pilot production test validation at its semiconductor contract manufacturer in Taiwan for a current high-volume device, and has requested evaluation of a second device in parallel.
On the package-level side, Erickson highlighted record follow-on production orders from Aehr’s lead hyperscale customer for Sonoma systems used in high-volume AI processor production burn-in. He said the customer is forecasting a substantial expansion of Sonoma purchases for a second device that has twice the power per package as the first device now using Sonoma systems.
Silicon Photonics, Power Semiconductors and Memory Opportunities Erickson said demand for silicon photonics burn-in is gaining momentum as AI data center architectures rely more heavily on optical I/O and high-speed optical interconnects. Aehr’s lead silicon photonics customer has placed follow-on orders, while another major silicon photonics customer, described as a global leader in networking products and solutions, has provided a forecast for additional systems this calendar year.
In power semiconductors, Aehr said it completed more than a dozen gallium nitride WaferPak designs now being sampled by potential customers, and completed what Erickson described as the world’s first 300-millimeter GaN wafer-level burn-in solution. The company also sold its first FOX system for a silicon MOSFET wafer-level burn-in application and secured its first silicon carbide customer in Taiwan.
Aehr announced about $8 million in new silicon carbide WaferPak orders in the past month, including expanded orders from its lead silicon carbide customer and an order directly from one of the largest automotive companies in the world for qualification of silicon carbide devices for new electric vehicles.
On memory, Erickson said Aehr continues to pursue NAND flash and potential high-bandwidth flash and DRAM applications. However, during the question-and-answer session, he said the company does not currently anticipate memory revenue in its fiscal 2027 guidance, adding that any memory-related upside would be incremental.
Capacity Buildout Underway Siu said Aehr continues to scale manufacturing capacity, including its Fremont expansion and the start of Sonoma system shipments from an existing contract manufacturer in Southeast Asia. He said that arrangement adds capacity for more than 20 additional Sonoma systems per month.
Erickson said Aehr does not believe it is capacity-limited at the $150 million revenue level and is working to maintain flexibility without building excessive fixed infrastructure. In response to analyst questions, he said the company is preparing for larger customer opportunities while acknowledging that execution remains complex due to supply chain and component considerations.
“With multiple customers entering or expanding production, a record backlog, and additional opportunities under discussion for both wafer level and package level burn-in, we believe Aehr is well-positioned for multiple years of strong revenue growth,” Erickson said.
About Aehr Test Systems NASDAQ: AEHRAehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.
The company's product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Aehr Test Systems Right Now?Before you consider Aehr Test Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aehr Test Systems wasn't on the list.
While Aehr Test Systems currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Main Street Capital (MAIN - Free Report) closed the most recent trading day at $53.09, moving +1.1% from the previous trading session. This change outpaced the S&P 500's 0.38% gain on the day. On the other hand, the Dow registered a gain of 0.02%, and the technology-centric Nasdaq increased by 0.9%.
Coming into today, shares of the investment firm had gained 2.38% in the past month. In that same time, the Finance sector gained 2.89%, while the S&P 500 gained 1.27%.
The upcoming earnings release of Main Street Capital will be of great interest to investors. It is anticipated that the company will report an EPS of $1.01, marking a 2.02% rise compared to the same quarter of the previous year. Simultaneously, our latest consensus estimate expects the revenue to be $143.23 million, showing a 0.52% drop compared to the year-ago quarter.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $4 per share and revenue of $580.63 million. These totals would mark changes of -4.99% and +2.51%, respectively, from last year.
Investors should also note any recent changes to analyst estimates for Main Street Capital. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Right now, Main Street Capital possesses a Zacks Rank of #4 (Sell).
Looking at valuation, Main Street Capital is presently trading at a Forward P/E ratio of 13.14. This indicates a premium in contrast to its industry's Forward P/E of 7.99.
The Financial - SBIC & Commercial Industry industry is part of the Finance sector. This group has a Zacks Industry Rank of 228, putting it in the bottom 8% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
Recursion Pharmaceuticals (RXRX - Free Report) ended the recent trading session at $3.34, demonstrating a +1.21% change from the preceding day's closing price. The stock outpaced the S&P 500's daily gain of 0.38%. Meanwhile, the Dow gained 0.02%, and the Nasdaq, a tech-heavy index, added 0.9%.
The stock of biotechnology company has risen by 0.3% in the past month, lagging the Medical sector's gain of 4.34% and the S&P 500's gain of 1.27%.
The investment community will be closely monitoring the performance of Recursion Pharmaceuticals in its forthcoming earnings report. The company is forecasted to report an EPS of -$0.25, showcasing a 39.02% upward movement from the corresponding quarter of the prior year. Meanwhile, our latest consensus estimate is calling for revenue of $11.99 million, down 37.64% from the prior-year quarter.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of -$0.99 per share and a revenue of $54.08 million, representing changes of +31.25% and -27.59%, respectively, from the prior year.
It is also important to note the recent changes to analyst estimates for Recursion Pharmaceuticals. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. As of now, Recursion Pharmaceuticals holds a Zacks Rank of #3 (Hold).
The Medical - Biomedical and Genetics industry is part of the Medical sector. With its current Zacks Industry Rank of 163, this industry ranks in the bottom 34% of all industries, numbering over 250.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
If you purchased or acquired stock in Ensign and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at [email protected] or by telephone at (212) 355-4648.
Click here to participate in the action.
NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) --
What’s Happening:
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against The Ensign Group, Inc. (“Ensign” or the “Company”) (NASDAQ:ENSG) on behalf of Ensign stockholders. Our investigation concerns whether Ensign has violated the federal securities laws and/or engaged in other unlawful business practices. Investigation Details:
On June 8, 2026, Hunterbrook published a short report alleging that Ensign Group's business model relies on inadequate patient care and gaming quality metrics. The Hunterbrook report further alleges that Ensign Group's profits depend on understaffing facilities while routing taxpayer dollars to executives and affiliates, and that patients have suffered and died as a result.
Following publication of the Hunterbrook report, Ensign Group's stock price fell $13.88 per share, or 8.15%, to close at $156.42 per share on June 8, 2026. Next Steps:
If you purchased or otherwise acquired Ensign shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at [email protected], by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in securities, derivative, and commercial litigation as well as individuals in consumer protection and data privacy litigation. The firm has a nationwide practice and routinely handles cases in both federal and state courts. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Follow us for updates on LinkedIn and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn.
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of TriCo Bancshares (NasdaqGS: TCBK) to First Hawaiian, Inc. (NasdaqGS: FHB). Under the terms of the proposed transaction, shareholders of TriCo will receive 2.095 First Hawaiian shares for each share of TriCo that they own. Upon closing of the Proposed Transaction, TriCo shareholders are expected to ow.
In the latest close session, Marathon Petroleum (MPC - Free Report) was up +2.2% at $303.40. This change outpaced the S&P 500's 0.38% gain on the day. Meanwhile, the Dow gained 0.02%, and the Nasdaq, a tech-heavy index, added 0.9%.
The refiner's stock has climbed by 18.34% in the past month, exceeding the Oils-Energy sector's loss of 1.55% and the S&P 500's gain of 1.27%.
The investment community will be closely monitoring the performance of Marathon Petroleum in its forthcoming earnings report. The company is scheduled to release its earnings on August 4, 2026. On that day, Marathon Petroleum is projected to report earnings of $13.26 per share, which would represent year-over-year growth of 234.85%. Simultaneously, our latest consensus estimate expects the revenue to be $34.83 billion, showing a 2.14% escalation compared to the year-ago quarter.
For the full year, the Zacks Consensus Estimates are projecting earnings of $33 per share and revenue of $144.77 billion, which would represent changes of +208.41% and +7.06%, respectively, from the prior year.
Investors might also notice recent changes to analyst estimates for Marathon Petroleum. Such recent modifications usually signify the changing landscape of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 2.59% higher. Marathon Petroleum presently features a Zacks Rank of #3 (Hold).
In terms of valuation, Marathon Petroleum is currently trading at a Forward P/E ratio of 9. This valuation marks a discount compared to its industry average Forward P/E of 9.53.
Investors should also note that MPC has a PEG ratio of 0.43 right now. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Oil and Gas - Refining and Marketing was holding an average PEG ratio of 0.37 at yesterday's closing price.
The Oil and Gas - Refining and Marketing industry is part of the Oils-Energy sector. Currently, this industry holds a Zacks Industry Rank of 45, positioning it in the top 19% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
Boston Scientific (BSX - Free Report) closed at $42.63 in the latest trading session, marking a -4.52% move from the prior day. This change lagged the S&P 500's 0.38% gain on the day. Elsewhere, the Dow saw an upswing of 0.02%, while the tech-heavy Nasdaq appreciated by 0.9%.
Shares of the medical device manufacturer witnessed a loss of 4.51% over the previous month, trailing the performance of the Medical sector with its gain of 4.34%, and the S&P 500's gain of 1.27%.
The investment community will be closely monitoring the performance of Boston Scientific in its forthcoming earnings report. The company is scheduled to release its earnings on July 29, 2026. The company's upcoming EPS is projected at $0.83, signifying a 10.67% increase compared to the same quarter of the previous year. Alongside, our most recent consensus estimate is anticipating revenue of $5.39 billion, indicating a 6.54% upward movement from the same quarter last year.
For the full year, the Zacks Consensus Estimates are projecting earnings of $3.36 per share and revenue of $21.61 billion, which would represent changes of +9.8% and +7.65%, respectively, from the prior year.
Investors might also notice recent changes to analyst estimates for Boston Scientific. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.02% lower. At present, Boston Scientific boasts a Zacks Rank of #4 (Sell).
Looking at its valuation, Boston Scientific is holding a Forward P/E ratio of 13.3. This signifies a discount in comparison to the average Forward P/E of 19.3 for its industry.
It is also worth noting that BSX currently has a PEG ratio of 0.85. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. As the market closed yesterday, the Medical - Products industry was having an average PEG ratio of 1.75.
The Medical - Products industry is part of the Medical sector. This group has a Zacks Industry Rank of 201, putting it in the bottom 19% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
M/I Homes (MHO - Free Report) closed at $148.11 in the latest trading session, marking a +1.4% move from the prior day. The stock outpaced the S&P 500's daily gain of 0.38%. Elsewhere, the Dow gained 0.02%, while the tech-heavy Nasdaq added 0.9%.
The homebuilder's stock has climbed by 3.38% in the past month, exceeding the Construction sector's loss of 3.74% and the S&P 500's gain of 1.27%.
The upcoming earnings release of M/I Homes will be of great interest to investors. The company's earnings report is expected on July 29, 2026. In that report, analysts expect M/I Homes to post earnings of $3.17 per share. This would mark a year-over-year decline of 28.28%. At the same time, our most recent consensus estimate is projecting a revenue of $1.18 billion, reflecting a 1.84% rise from the equivalent quarter last year.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $12.6 per share and a revenue of $4.37 billion, indicating changes of -14.52% and -0.98%, respectively, from the former year.
It is also important to note the recent changes to analyst estimates for M/I Homes. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. M/I Homes presently features a Zacks Rank of #3 (Hold).
With respect to valuation, M/I Homes is currently being traded at a Forward P/E ratio of 11.59. This expresses a discount compared to the average Forward P/E of 14.45 of its industry.
The Building Products - Home Builders industry is part of the Construction sector. This industry, currently bearing a Zacks Industry Rank of 194, finds itself in the bottom 22% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
In the latest close session, Celsius Holdings Inc. (CELH - Free Report) was up +1.04% at $30.14. This move outpaced the S&P 500's daily gain of 0.38%. At the same time, the Dow added 0.02%, and the tech-heavy Nasdaq gained 0.9%.
Shares of the company have appreciated by 3.79% over the course of the past month, outperforming the Consumer Staples sector's loss of 0.78%, and the S&P 500's gain of 1.27%.
The investment community will be closely monitoring the performance of Celsius Holdings Inc. in its forthcoming earnings report. The company is predicted to post an EPS of $0.42, indicating a 10.64% decline compared to the equivalent quarter last year. Alongside, our most recent consensus estimate is anticipating revenue of $891.45 million, indicating a 20.59% upward movement from the same quarter last year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $1.59 per share and revenue of $3.33 billion. These totals would mark changes of +18.66% and +32.32%, respectively, from last year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Celsius Holdings Inc. These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate has moved 0.26% higher within the past month. Celsius Holdings Inc. is holding a Zacks Rank of #4 (Sell) right now.
In terms of valuation, Celsius Holdings Inc. is presently being traded at a Forward P/E ratio of 18.76. This valuation marks a premium compared to its industry average Forward P/E of 13.23.
We can also see that CELH currently has a PEG ratio of 1.19. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Food - Miscellaneous was holding an average PEG ratio of 2.52 at yesterday's closing price.
The Food - Miscellaneous industry is part of the Consumer Staples sector. At present, this industry carries a Zacks Industry Rank of 214, placing it within the bottom 14% of over 250 industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
, /PRNewswire/ -- Das Jane Goodall Institute (JGI) USA und FormationQ haben heute eine bahnbrechende Forschungspartnerschaft bekannt gegeben, in deren Rahmen die von IonQ entwickelte Quantencomputertechnologie auf Basis gefangener Ionen zur Erforschung einer der seit langem bestehenden Fragen der Verhaltensökologie eingesetzt werden soll: Warum üben manche Spezies tödliche Gewalt zwischen verschiedenen Gruppen aus, während andere friedlich mit ihren Nachbarn zusammenleben?
Das auf zwei Jahre angelegte Programm, das am Welt-Schimpansen-Tag startet – dem 66. Jahrestag der Ankunft von Dr. Jane Goodall in Gombe, Tansania, wo sie ihre Forschungen an wildlebenden Schimpansen begann –, baut auf mehr als sechs Jahrzehnten bahnbrechender Feldforschung auf und vereint fortschrittliche computergestützte Modellierung, hybrides quanten-klassisches Rechnen und Verhaltensökologie in einem neuen, zukunftsweisenden Rahmen für die gemeinsame Forschung.
Das Programm Ecology of War and Peace: Using Quantum-Enhanced Agent-Based Modelling to Explain Contrasting Intergroup Behaviour in Chimpanzees and Bonobos (Ökologie von Krieg und Frieden: Einsatz quantenverstärkter agentenbasierter Modellierung zur Erklärung gegensätzlicher Verhaltensweisen zwischen Gruppen bei Schimpansen und Bonobos) wird die erste Anwendung ihrer Art sein, bei der quantengestützte Berechnungen zur Erforschung von Ökologie, Evolution und Verhalten eingesetzt werden. Damit wird ein mutiges neues Kapitel in der jahrzehntelangen Tradition des Jane Goodall Institute USA aufgeschlagen, innovative Technologien zur Unterstützung langfristiger Forschung, Naturschutz und Bildung einzusetzen.
Das Programm wird das unvergleichliche wissenschaftliche Erbe des JGI, die von Forschern der University of Minnesota entwickelten Verhaltensmodelle, die Expertise von FormationQ bei der Konzeption und Durchführung anwendungsorientierter Programme sowie die Quantencomputing-Plattform von IonQ miteinander vereinen.
Im Mittelpunkt des Programms steht B3GET (Behaviour, Ecology, Genetics, Evolution and Tradeoffs – zu Deutsch: Verhalten, Ökologie, Genetik, Evolution und Zielkonflikte), ein ausgeklügeltes agentenbasiertes Modell, in dem virtuelle Primaten in künstlichen Landschaften leben, sich fortbewegen, nach Nahrung suchen, sich fortpflanzen und miteinander interagieren. Forscher können ökologische Bedingungen, darunter die Nahrungsverteilung, die Größe des Lebensraums und die Regeln für den Gruppenzusammenhalt, systematisch variieren, um zu untersuchen, wie Umweltfaktoren die Muster der Zusammenarbeit und der Konflikte im Laufe der Zeit beeinflussen.
Schimpansen und Bonobos sind die beiden nächsten lebenden Verwandten des Menschen, weisen jedoch auffallend unterschiedliche Verhaltensmuster im Umgang mit anderen Gruppen auf. Jane Goodall beobachtete in den 1970er Jahren die berühmten Kriege unter Schimpansen, bei denen diese in organisierte, tödliche Konflikte zwischen verschiedenen Gruppen verwickelt waren. Bonobos hingegen sind für ihr friedliches Miteinander zwischen verschiedenen Gruppen bekannt.
Forscher glauben, dass die Erklärung für diesen Unterschied in der Ökologie zu finden ist: in der Art und Weise, wie Nahrung in der Landschaft verteilt ist, in der Größe der Reviere, die jede Art abdecken muss, und in den von Moment zu Moment getroffenen Entscheidungen der einzelnen Tiere, ob sie allein oder in Gruppen unterwegs sind. Jahrzehntelange Feldforschung hat außergewöhnliche Einblicke in diese Verhaltensweisen geliefert. Zu verstehen, wie zahlreiche ökologische Variablen in komplexen Systemen miteinander interagieren, stellt jedoch nach wie vor eine große Herausforderung dar.
Durch die Kombination fortschrittlicher agentenbasierter Modellierung mit hybriden quanten-klassischen Berechnungsansätzen wird das Programm untersuchen, wie Quantencomputing Forschern dabei helfen kann, diesen komplexen Raum auf neue Weise zu erforschen und die Kalibrierung groß angelegter Verhaltensmodelle zu verbessern, um so die ökologischen Bedingungen zu identifizieren, die die tödliche Aggression zwischen Gruppen bei Schimpansen von der friedlicheren Koexistenz der Bonobos unterscheiden.
Das Projekt wird zudem Aufschluss darüber geben, inwiefern das natürliche Verhalten von Schimpansen mit ihrem Lebensraum und einer erhöhten Sterblichkeitsrate zusammenhängt. Beide Faktoren sind von entscheidender Bedeutung, um nicht nur Schimpansen besser zu verstehen, sondern auch Lebensräume besser zu identifizieren und zu schützen sowie Schimpansenpopulationen zu modellieren, um wirksamere Schutzstrategien zu entwickeln.
Dr. Lilian Pintea, Vizepräsidentin für Naturschutzforschung am Jane Goodall Institute und Projektleiterin, erklärte:
„Dr. Jane Goodall hat über 65 Jahre damit verbracht, die umfassendste fortlaufende Dokumentation über wild lebende Schimpansen aufzubauen. Dieses Vermächtnis geduldiger und gründlicher Beobachtung trifft nun auf die Grenzen der Quantenwissenschaft. Das Verständnis der ökologischen Bedingungen, die die Interaktion der Schimpansen mit ihren Lebensräumen und Nachbarn bestimmen, ist auch entscheidend, um zu verstehen, warum Populationen gedeihen oder zurückgehen und wo Naturschutzmaßnahmen am wirksamsten sind."
„Diese Partnerschaft verkörpert genau das, wofür die wissenschaftliche Arbeit des Jane Goodall Institute steht: die strategische Nutzung der leistungsfähigsten verfügbaren technologischen Mittel, um die Fragen anzugehen, die für Schimpansen, für den Artenschutz und für unser Verständnis dessen, was es bedeutet, Mensch zu sein, von größter Bedeutung sind. Dieses Programm ist eines der letzten, an denen Jane und ich gemeinsam gearbeitet haben. Es heute, am 66. Jahrestag ihres ersten Tages in Gombe, starten zu können, ist für mich von großer Bedeutung."
Nada Hosking, Gründerin und Geschäftsführerin von FormationQ, sagte:
„Dieses Programm beginnt mit einer tiefgreifenden wissenschaftlichen Fragestellung, jahrzehntelanger außergewöhnlicher Feldforschung und einem ausgefeilten Modell, das entwickelt wurde, um ein äußerst komplexes natürliches System zu verstehen. Die Rolle von FormationQ im Rahmen dieser Partnerschaft besteht darin, diese Elemente mit den bahnbrechenden Quantencomputing-Fähigkeiten von IonQ zu vereinen und ein Forschungsprogramm rund um eine Fragestellung aufzubauen, die bisher noch nie auf diese Weise angegangen wurde."
„Wir sind davon überzeugt, dass sich das wahre Potenzial der Quantentechnologie erst dann entfalten wird, wenn weltweit führendes Fachwissen, Daten und Modelle so mit dieser Technologie verknüpft werden, dass Forscher neue Fragen stellen können. Es gibt wohl kaum einen sinnvolleren Ausgangspunkt als Jane Goodalls außergewöhnliches wissenschaftliches Vermächtnis und das, was es uns noch immer über die Natur, den Naturschutz und uns selbst lehren kann."
Hinweise für Redakteure
B3GET wurde von Dr. Kristin N. Crouse, einer Postdoktorandin an der University of Minnesota, entwickelt, die als Mitforscherin und hauptamtliche Forschungsleiterin an dem Projekt mitwirken wird. Zum Projektteam gehört außerdem Dr. Michael L. Wilson als Mitforscher vom College of Biological Sciences der University of Minnesota; die Forschungsinfrastruktur wird vom Supercomputing Institute der University of Minnesota bereitgestellt. Michael Wilson, Professor für Ökologie, Evolution und Verhalten, ist leitender Forscher des Gombe Research Consortium und kann auf über 25 Jahre Erfahrung im Rahmen des Gombe-Schimpansenprojekts zurückblicken, einschließlich drei Jahren als Leiter der Feldforschung am Gombe Stream Research Centre.
Das Jane Goodall Institute (JGI) USA bringt Erkenntnisse aus über 65 Jahren Feldforschung ein und unterstützt die Festlegung der Schwerpunkte dieses Forschungsprogramms mit seinem fachlichen Know-how. FormationQ wird die Partner zusammenbringen und die angewandte Quantenkomponente des Programms konzipieren und betreiben, während IonQ die Quantencomputing-Plattform sowie die technischen Kapazitäten auf Basis seiner Ionenfalle-Systeme bereitstellen wird.
Informationen zum Jane-Goodall-Institut
Das Jane Goodall Institute (JGI) ist eine 1977 gegründete globale Naturschutzorganisation, die das Vermächtnis von Dr. Jane Goodall in 30 Niederlassungen weltweit weiterführt. Das Jane Goodall Institute führt Janes Vision fort, Hoffnung zu wecken und diese durch wissenschaftlich fundierte, technologisch gestützte Programme in konkrete Maßnahmen umzusetzen, die sich auf die Erforschung und Rehabilitation von Wildtieren, gemeindegeleiteten Naturschutz sowie die Einbindung junger Menschen konzentrieren. Durch das Jugendprogramm Jane Goodalls Roots & Shoots, das mittlerweile in 75 Ländern weltweit aktiv ist – Tendenz steigend –, schafft das JGI eine Bewegung mitfühlender Menschen, die sich für die Mission der Organisation einsetzen, eine bessere Welt für Menschen, andere Tiere und unsere gemeinsame Umwelt zu schaffen.
Weitere Informationen finden Sie unter JaneGoodall.org und RootsAndShoots.org. Folgen Sie @JaneGoodallInst und @RootsAndShoots.
Informationen zu FormationQ
FormationQ ist die Enablement-Schicht für die weltweite Einführung der Quantentechnologie. Das Unternehmen entwickelt institutionelle Wege und Kooperationsstrukturen, die es ermöglichen, Quantentechnologien aus der Spitzenforschung in die praktische Anwendung zu überführen. In Zusammenarbeit mit führenden Institutionen und Technologiepartnern betreibt und unterstützt FormationQ Programme, die die Talentförderung, die Anwendungsentwicklung und die Koordination des Ökosystems auf eine Weise vorantreiben, die kontrollierbar, vertrauenswürdig und langfristig nachhaltig ist.
Informationen zu IonQ
IonQ, Inc. [NYSE: IONQ] ist die führende Quantenplattform und -foundry weltweit und stellt integrierte Quantenlösungen in den Bereichen Rechenleistung, Netzwerke, Sensorik und Sicherheit bereit. Die neueste Generation von Quantencomputern von IonQ, der IonQ Tempo, ist das jüngste Modell einer Reihe von hochmodernen Systemen, die Kunden und Partnern wie Amazon Web Services, NVIDIA und AstraZeneca dabei helfen, eine 20-fache Leistungssteigerung zu erzielen und Innovationen in den Bereichen Arzneimittelforschung, Materialwissenschaften, Finanzmodellierung, Logistik, Cybersicherheit und Verteidigung voranzutreiben. 2025 erreichte das Unternehmen eine 99,99-prozentige Zwei-Qubit-Gattertreue und stellte damit einen Weltrekord in der Quantencomputing-Leistung auf.
IonQ hat seinen Hauptsitz in College Park, Maryland, und unterhält Niederlassungen in Kalifornien, Colorado, Massachusetts, Tennessee, Washington, Italien, Südkorea, Schweden, der Schweiz, Kanada und dem Vereinigten Königreich. Unsere Quantencomputing-Dienste sind über alle großen Cloud-Anbieter verfügbar, während wir gleichzeitig die Anforderungen von Kunden aus den Bereichen Netzwerke und Sensorik zu Lande, zu Wasser, in der Luft und im Weltraum erfüllen. IonQ macht Quantenplattformen zugänglicher und wirkungsvoller als je zuvor. Weitere Informationen finden Sie unter IonQ.com.
San Diego, California--(Newsfile Corp. - July 14, 2026) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Peabody Energy Corporation (NYSE: BTU) common stock between October 14, 2024 and May 4, 2026, inclusive (the "Class Period"), have until Monday, August 24, 2026 to seek appointment as lead plaintiff of the Peabody Energy class action lawsuit. Captioned McGeachy v. Peabody Energy Corporation, No. 26-cv-01020 (E.D. Mo.), the Peabody Energy class action lawsuit charges Peabody Energy and certain of Peabody Energy's top current and former executive officers with violations of the Securities Exchange Act of 1934.
If you suffered substantial losses and wish to serve as lead plaintiff of the Peabody Energy class action lawsuit, please provide your information here:
You can also contact attorneys Ken Dolitsky or Michael Albert of Robbins Geller by calling 800/851-7783 or via e-mail at [email protected].
CASE ALLEGATIONS: Peabody Energy engages in the production of metallurgical and thermal coal.
The Peabody Energy class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) defendants created the false impression that they possessed reliable information pertaining to Peabody Energy's Centurion mine ramp-up and anticipated growth; and (ii) there was a multitude of issues causing delays to the Centurion mine ramp-up and the return to full longwall production dates.
On March 30, 2026, Peabody Energy issued a press release allegedly lowering guidance pertaining to Centurion mine's expected first quarter 2026 output by 450,000 tons ahead of Peabody Energy's full earnings release. On this news, the price of Peabody Energy stock fell nearly 10%, according to the complaint.
Then, on May 5, 2026, Peabody Energy issued a press release allegedly disclosing Peabody Energy's failure to ramp-up Centurion by the long-awaited March 2026 deadline and that Peabody Energy was cutting guidance related to full year met segment volumes to reflect the increased cost and substantial volume decrease. On this news, the price of Peabody Energy stock fell nearly 6%, according to the complaint.
THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Peabody Energy common stock during the Class Period to seek appointment as lead plaintiff in the Peabody Energy class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Peabody Energy class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Peabody Energy class action lawsuit. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Peabody Energy class action lawsuit.
ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder rights litigation. Our Firm ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report, recovering more than $916 million for investors in 2025. This marks our fourth #1 ranking in the past five years. And in those five years alone, Robbins Geller recovered $8.4 billion for investors — $3.4 billion more than any other law firm. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever — $7.2 billion — in In re Enron Corp. Sec. Litig. Please visit the following page for more information:
Valero Energy (VLO - Free Report) ended the recent trading session at $301.43, demonstrating a +1.91% change from the preceding day's closing price. This move outpaced the S&P 500's daily gain of 0.38%. At the same time, the Dow added 0.02%, and the tech-heavy Nasdaq gained 0.9%.
The oil refiner's stock has climbed by 19.68% in the past month, exceeding the Oils-Energy sector's loss of 1.55% and the S&P 500's gain of 1.27%.
Market participants will be closely following the financial results of Valero Energy in its upcoming release. The company plans to announce its earnings on July 30, 2026. It is anticipated that the company will report an EPS of $9.81, marking a 330.26% rise compared to the same quarter of the previous year. Simultaneously, our latest consensus estimate expects the revenue to be $35.92 billion, showing a 20.18% escalation compared to the year-ago quarter.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $31.04 per share and revenue of $134.62 billion, indicating changes of +192.55% and +9.73%, respectively, compared to the previous year.
Any recent changes to analyst estimates for Valero Energy should also be noted by investors. Such recent modifications usually signify the changing landscape of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. The Zacks Consensus EPS estimate has moved 13.91% higher within the past month. Valero Energy is holding a Zacks Rank of #3 (Hold) right now.
Valuation is also important, so investors should note that Valero Energy has a Forward P/E ratio of 9.53 right now. This denotes no noticeable deviation relative to the industry average Forward P/E of 9.53.
Meanwhile, VLO's PEG ratio is currently 0.37. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. Oil and Gas - Refining and Marketing stocks are, on average, holding a PEG ratio of 0.37 based on yesterday's closing prices.
The Oil and Gas - Refining and Marketing industry is part of the Oils-Energy sector. This industry, currently bearing a Zacks Industry Rank of 45, finds itself in the top 19% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
Sunrun (RUN - Free Report) closed the most recent trading day at $12.78, moving +2.98% from the previous trading session. The stock's change was more than the S&P 500's daily gain of 0.38%. Meanwhile, the Dow experienced a rise of 0.02%, and the technology-dominated Nasdaq saw an increase of 0.9%.
The stock of solar energy products distributor has fallen by 0.48% in the past month, leading the Oils-Energy sector's loss of 1.55% and undershooting the S&P 500's gain of 1.27%.
The upcoming earnings release of Sunrun will be of great interest to investors. The company's upcoming EPS is projected at $0.08, signifying a 92.52% drop compared to the same quarter of the previous year. Meanwhile, the latest consensus estimate predicts the revenue to be $722.86 million, indicating a 26.96% increase compared to the same quarter of the previous year.
For the full year, the Zacks Consensus Estimates are projecting earnings of $1.01 per share and revenue of $3.08 billion, which would represent changes of -40.94% and +4.14%, respectively, from the prior year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Sunrun. These revisions typically reflect the latest short-term business trends, which can change frequently. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 7.11% lower within the past month. Sunrun currently has a Zacks Rank of #4 (Sell).
Valuation is also important, so investors should note that Sunrun has a Forward P/E ratio of 12.26 right now. For comparison, its industry has an average Forward P/E of 20.52, which means Sunrun is trading at a discount to the group.
The Solar industry is part of the Oils-Energy sector. At present, this industry carries a Zacks Industry Rank of 52, placing it within the top 22% of over 250 industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
Investors looking at the future of computing often find themselves choosing between Cadence Design Systems (CDNS 0.30%) and Synopsys (SNPS 1.74%). Both companies provide the essential software tools needed to design the worlds most advanced computer chips.
While they operate in a similar niche, their financial profiles and recent acquisitions have created two distinct paths for investors. This comparison looks at which stock offers the more compelling balance of growth and risk today.
Cadence Design Systems sells specialized software and hardware that engineers use to design complex computer chips and electromechanical systems. Its tools are vital for customers in the mobile, automotive, and aerospace sectors who need to simulate how their designs will perform in the real world. Recent commercial agreements include a multi-year partnership with Intel and a strategic testing project with Samsung Foundry to advance 2nm chip designs in the semiconductor stocks category.
In FY 2025, revenue reached nearly $5.3 billion, representing a growth rate of approximately 14.1% compared to the previous year. The company reported net income of close to $1.1 billion for the same period. This resulted in a net margin, which measures how much profit a company keeps from every dollar of sales, of roughly 20.9%.
As of its December 2025 balance sheet, the debt-to-equity ratio stood at approximately 0.5x. This metric compares a company's total debt to its shareholder equity to assess financial leverage. The current ratio, which measures the ability to cover short-term debts with short-term assets, was roughly 2.9x. Free cash flow, or the cash remaining after paying for operations and equipment, reached nearly $1.6 billion. Note that stock-based compensation represented roughly 26.3% of operating cash flow, which inflates reported cash generation since this is a non-cash expense added back in the cash flow statement.
The case for SynopsysSynopsys provides silicon-to-systems engineering solutions that include silicon design, intellectual property, and simulation tools. The company serves global customers across markets like data centers and autonomous machines. A key recent partnership with Murata Manufacturing has expanded its simulation models for thermal and electromagnetic analysis.
In FY 2025, revenue reached nearly $7.1 billion, which was a growth of approximately 15.1% over the prior year. Net income for the period was close to $1.3 billion. The company achieved a net margin of roughly 19% during this fiscal year.
As of its October 2025 balance sheet, the debt-to-equity ratio was approximately 0.5x. The current ratio, representing the company's short term liquidity, was roughly 1.6x. Free cash flow for the year reached close to $1.3 billion. Note that stock-based compensation represented roughly 58.8% of operating cash flow, meaning reported cash generation is heavily inflated by this non-cash add-back.
Risk profile comparisonCadence Design Systems faces risks regarding strict monitoring from the July 2025 export control settlement. It also navigates complex intellectual property risks related to its heavy investment in generative and agentic artificial intelligence. Furthermore, the integration of acquisitions like Hexagon requires managing significant operational and cybersecurity challenges.
Synopsys is currently managing multiple class action lawsuits that allege misstatements regarding its intellectual property segment performance. The large-scale merger with Ansys carries risks of operational friction and potentially lower-than-expected synergies. Additionally, the company faces potential strategic shifts following a settlement with Elliott Investment Management.
Valuation comparisonSynopsys appears to be the more affordable option based on future earnings estimates and current sales multiples.
MetricCadence Design SystemsSynopsysSector BenchmarkForward P/E48.6x30.0x357.9xP/S ratio20.1x12.0xSector benchmark uses the SPDR XLK sector ETF.
Valuation metrics sourced from Financial Modeling Prep (FMP) and may differ from other data providers.
Which stock would I buy in 2026?This is a close call, but I'd give the edge to Cadence. Both companies sit at the center of one of the most important trends in technology right now: The insatiable demand for more powerful, more efficient chips. And both are benefiting from it in a big way.
Synopsys made a bold move by acquiring Ansys last year, dramatically expanding its reach from chip design into broader engineering simulation. The backlog is enormous, and the long-term strategic logic makes sense. But integrating an acquisition of that size takes time, introduces complexity, and carries a significant debt load that will take years to work down.
Cadence is a cleaner story right now. Its backlog just hit a record, it raised its full-year outlook after a strong quarter, and it is growing profitably across every part of its business. Its AI-powered design tools are winning new customers, and the balance sheet is in excellent shape.
Both companies will likely do well over the long term. But Cadence lets you own the chip design boom without the integration overhang.
Hershey (HSY - Free Report) closed at $171.46 in the latest trading session, marking a -2.16% move from the prior day. The stock's change was less than the S&P 500's daily gain of 0.38%. Meanwhile, the Dow gained 0.02%, and the Nasdaq, a tech-heavy index, added 0.9%.
The chocolate bar and candy maker's stock has dropped by 3.24% in the past month, falling short of the Consumer Staples sector's loss of 0.78% and the S&P 500's gain of 1.27%.
Analysts and investors alike will be keeping a close eye on the performance of Hershey in its upcoming earnings disclosure. The company's earnings report is set to go public on July 30, 2026. The company is predicted to post an EPS of $1.46, indicating a 20.66% growth compared to the equivalent quarter last year. In the meantime, our current consensus estimate forecasts the revenue to be $2.66 billion, indicating a 1.7% growth compared to the corresponding quarter of the prior year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $8.43 per share and a revenue of $12.29 billion, signifying shifts of +33.6% and +5.07%, respectively, from the last year.
Investors should also take note of any recent adjustments to analyst estimates for Hershey. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.22% lower. Hershey is holding a Zacks Rank of #3 (Hold) right now.
With respect to valuation, Hershey is currently being traded at a Forward P/E ratio of 20.79. This denotes a premium relative to the industry average Forward P/E of 19.82.
We can additionally observe that HSY currently boasts a PEG ratio of 1.05. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Food - Confectionery industry currently had an average PEG ratio of 1.05 as of yesterday's close.
The Food - Confectionery industry is part of the Consumer Staples sector. This industry, currently bearing a Zacks Industry Rank of 223, finds itself in the bottom 10% echelons of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
In the latest close session, CRH (CRH - Free Report) was up +1.17% at $103.91. This move outpaced the S&P 500's daily gain of 0.38%. On the other hand, the Dow registered a gain of 0.02%, and the technology-centric Nasdaq increased by 0.9%.
Heading into today, shares of the building material company had lost 6.28% over the past month, lagging the Construction sector's loss of 3.74% and the S&P 500's gain of 1.27%.
The investment community will be paying close attention to the earnings performance of CRH in its upcoming release. The company is slated to reveal its earnings on July 30, 2026. The company's upcoming EPS is projected at $1.96, signifying a 1.03% increase compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $10.67 billion, up 4.57% from the prior-year quarter.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $5.92 per share and revenue of $39.84 billion, indicating changes of +6.28% and +6.39%, respectively, compared to the previous year.
Investors should also take note of any recent adjustments to analyst estimates for CRH. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. CRH is currently a Zacks Rank #2 (Buy).
In terms of valuation, CRH is currently trading at a Forward P/E ratio of 17.36. This represents a discount compared to its industry average Forward P/E of 17.72.
Also, we should mention that CRH has a PEG ratio of 1.79. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. CRH's industry had an average PEG ratio of 1.5 as of yesterday's close.
The Building Products - Miscellaneous industry is part of the Construction sector. This industry currently has a Zacks Industry Rank of 182, which puts it in the bottom 27% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
In the latest close session, Hasbro (HAS - Free Report) was down 1.4% at $78.42. The stock's performance was behind the S&P 500's daily gain of 0.38%. Meanwhile, the Dow experienced a rise of 0.02%, and the technology-dominated Nasdaq saw an increase of 0.9%.
Prior to today's trading, shares of the toy maker had lost 6.42% lagged the Consumer Discretionary sector's loss of 0.81% and the S&P 500's gain of 1.27%.
Market participants will be closely following the financial results of Hasbro in its upcoming release. The company plans to announce its earnings on July 21, 2026. It is anticipated that the company will report an EPS of $1.13, marking a 13.08% fall compared to the same quarter of the previous year. In the meantime, our current consensus estimate forecasts the revenue to be $1.04 billion, indicating a 6.13% growth compared to the corresponding quarter of the prior year.
HAS's full-year Zacks Consensus Estimates are calling for earnings of $6.03 per share and revenue of $4.99 billion. These results would represent year-over-year changes of +8.84% and +6.1%, respectively.
Investors might also notice recent changes to analyst estimates for Hasbro. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.32% higher within the past month. Currently, Hasbro is carrying a Zacks Rank of #3 (Hold).
Digging into valuation, Hasbro currently has a Forward P/E ratio of 13.2. This denotes a premium relative to the industry average Forward P/E of 10.23.
We can additionally observe that HAS currently boasts a PEG ratio of 1.94. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Toys - Games - Hobbies industry had an average PEG ratio of 1.58 as trading concluded yesterday.
The Toys - Games - Hobbies industry is part of the Consumer Discretionary sector. At present, this industry carries a Zacks Industry Rank of 48, placing it within the top 20% of over 250 industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
VANCOUVER, BC / ACCESS Newswire / July 14, 2026 / Arctic Fox Lithium Corp. (CSE:AFX)(FSE:O5K)(OTCQB:AFXLF) ("Arctic Fox" or, the "Company") is pleased to announce that it intends to change its name from Arctic Fox Lithium Corp. to NiobiumX Mining Inc. (the "Name Change") to better reflect its broadened mineral property portfolio.
In connection with the Name Change, the Company will be changing its trading symbol to (NIOX), and the Company's common shares will continue to trade on the Canadian Securities Exchange (CSE) under the new company name and ticker symbol (NIOX) as of market open on July 17, 2026.
The new CUSIP and ISIN numbers assigned to the Company's common shares are 653946103 and CA6539461039, respectively.
About Arctic Fox Lithium Corp.
Arctic Fox Lithium Corp. is a junior mineral exploration company focused on the acquisition and development of mineral properties.
For further information, please contact:
Kirby Renton, Director, President and CEO.
Phone: (604) 689-2646
On behalf of the Board of Directors,
Kirby Renton
Director, President and CEO
Arctic Fox Lithium Corp.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release.
Forward-Looking Information: Except for statements of historic fact this news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan" "expect" "project" "intend" "believe" "anticipate" "estimate" and other similar words or statements that certain events or conditions "may" or "will" occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward- looking statements including but not limited to the Name Change and other forward looking statements. There are uncertainties inherent in forward-looking information including factors beyond the Company's control. There are no assurances that the business plans for Arctic Fox described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company's filings with Canadian securities regulators which are available at www.sedarplus.ca
If you purchased or acquired Verra common stock between February 24, 2026, to May 26, 2026 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at [email protected], telephone at (212) 355-4648.
Click here to participate in the action.
NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) --
What’s Happening?
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Verra Mobility Corporation (“Verra Mobility” or the “Company”) (NASDAQ:VRRM) in the United States District Court for the District of Arizona on behalf of all persons and entities who purchased or otherwise acquired Verra common stock between February 24, 2026, to May 26, 2026, both dates inclusive (the “Class Period”). Investors have until August 4, 2026 to apply to the Court to be appointed as lead plaintiff in the lawsuit. What are the Allegation Details?
According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Verra’s relationship with Avis Budget Group (“Avis”), and in particular obtaining a contract extension with Avis. Further, the Company minimized concerns that major rent-a-cars could replace Verra with in-house solutions or outsourced alternatives. When the true details entered the market, the lawsuit claims that investors suffered damages. On May 26, 2026, Verra Mobility announced that it received a termination notice from Avis Budget Group, which becomes effective in September 2026. The Company further disclosed that it “expects the termination to reduce Commercial Services’ 2026 annualized revenue by approximately $135 million to $145 million and 2026 annualized segment profit by approximately $120 million to $125 million, before taking into account expected cost reduction initiatives.” The price of the Company’s stock dropped following this news. What are my Next Steps?
If you purchased or otherwise acquired Verra Mobility shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at [email protected], telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in securities, derivative, and commercial litigation as well as individuals in consumer protection and data privacy litigation. The firm has a nationwide practice and routinely handles cases in both federal and state courts. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Follow us for updates on LinkedIn and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn.
In the latest close session, Kyndryl Holdings, Inc. (KD - Free Report) was down 5.76% at $11.61. The stock fell short of the S&P 500, which registered a gain of 0.38% for the day. At the same time, the Dow added 0.02%, and the tech-heavy Nasdaq gained 0.9%.
The company's shares have seen an increase of 6.48% over the last month, surpassing the Business Services sector's gain of 3.64% and the S&P 500's gain of 1.27%.
Market participants will be closely following the financial results of Kyndryl Holdings, Inc. in its upcoming release. The company plans to announce its earnings on August 5, 2026. The company is expected to report EPS of $0.03, down 91.89% from the prior-year quarter. Alongside, our most recent consensus estimate is anticipating revenue of $3.68 billion, indicating a 1.74% downward movement from the same quarter last year.
For the full year, the Zacks Consensus Estimates are projecting earnings of $1.9 per share and revenue of $14.76 billion, which would represent changes of +30.14% and -2.19%, respectively, from the prior year.
Any recent changes to analyst estimates for Kyndryl Holdings, Inc. should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. Kyndryl Holdings, Inc. presently features a Zacks Rank of #3 (Hold).
Digging into valuation, Kyndryl Holdings, Inc. currently has a Forward P/E ratio of 6.48. Its industry sports an average Forward P/E of 16.85, so one might conclude that Kyndryl Holdings, Inc. is trading at a discount comparatively.
The Technology Services industry is part of the Business Services sector. This industry currently has a Zacks Industry Rank of 105, which puts it in the top 43% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow KD in the coming trading sessions, be sure to utilize Zacks.com.
NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Primoris Services Corporation (“Primoris” or the “Company”) (NYSE: PRIM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Primoris and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On May 5, 2026, Primoris issued a press release reporting its financial results for the first quarter of 2026. Primoris reported results below analyst expectations and slashed full-year adjusted EBITDA guidance from $560-$580 million to $480-$500 million. Primoris attributed the reduction to lower renewable energy activity, delayed project starts, and increased costs on renewable energy projects.
On this news, Primoris’s stock price fell $101.69 per share, or 50.11%, to close at $101.23 per share on May 6, 2026.
Then, on June 22, 2026, Primoris issued a press release “announc[ing] a series of business updates including the departure of its Chief Operating Officer (‘COO’), effective today.” The press release also disclosed that “[a]dditional challenges and cost overruns were identified as a result of continued progress on projects in the Company’s Renewables business, including through an ongoing assessment by a third-party industry expert.” Primoris advised that it “also anticipat[es] lower revenue and gross profit for the full year 2026, primarily driven by lower expected revenue and gross profit in the Renewables business” and “now expects revenue in the Renewables business for the full year 2026 to be approximately $2.1 billion, compared to approximately $3.0 billion for the full year of 2025.” Accordingly, Primoris disclosed that it “anticipat[es] lower revenue and gross profit for the full year 2026, primarily driven by lower expected revenue and gross profit in the Renewables business” and “now expects revenue in the Renewables business for the full year 2026 to be approximately $2.1 billion, compared to approximately $3.0 billion for the full year of 2025.”
On this news, Primoris’s stock price fell $23.39 per share, or 21.59%, to close at $84.95 per share on June 23, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Certara, Inc. (“Certara” or the “Company”) (NASDAQ: CERT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Certara and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On May 11, 2026, Certara reported its first quarter 2026 financial results. Certara disclosed that services revenue declined 4% year-over-year to $57.2 million, while services bookings declined 14% year-over-year to $66.6 million. In discussing the quarter, Certara said that it saw “softer performance from Tier 1 customers in MIDD services” and that services performance was “mixed.” The Company also announced its exit from the regulatory business in their service segment. I n response to a question about consistency between software and services performance, Certara said that there had been “a lot of inconsistency and back and forth” over the last few quarters.
On this news, Certara’s stock price fell $1.18 per share, or approximately 19%, to close at $5.13 on May 11, 2026.
Then, on June 17, 2026, Certara announced that John Gallagher, the Company’s Chief Financial Officer, had notified Certara of his intent to resign from his office effective as of the end of the day on July 14, 2026.
On this news, Certara’s stock price fell $0.49 per share, or 8.13%, to close at $5.54 per share on June 18, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
Duolingo, Inc. (DUOL - Free Report) closed at $128.35 in the latest trading session, marking a -3.01% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 0.38%. Elsewhere, the Dow saw an upswing of 0.02%, while the tech-heavy Nasdaq appreciated by 0.9%.
Shares of the company have appreciated by 4.16% over the course of the past month, outperforming the Business Services sector's gain of 3.64%, and the S&P 500's gain of 1.27%.
The upcoming earnings release of Duolingo, Inc. will be of great interest to investors. The company's earnings report is expected on August 5, 2026. It is anticipated that the company will report an EPS of $0.58, marking a 36.26% fall compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $296.19 million, up 17.42% from the prior-year quarter.
DUOL's full-year Zacks Consensus Estimates are calling for earnings of $2.76 per share and revenue of $1.21 billion. These results would represent year-over-year changes of -67.79% and +16.36%, respectively.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Duolingo, Inc. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. At present, Duolingo, Inc. boasts a Zacks Rank of #4 (Sell).
In terms of valuation, Duolingo, Inc. is presently being traded at a Forward P/E ratio of 47.92. For comparison, its industry has an average Forward P/E of 16.85, which means Duolingo, Inc. is trading at a premium to the group.
One should further note that DUOL currently holds a PEG ratio of 1.03. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. As of the close of trade yesterday, the Technology Services industry held an average PEG ratio of 1.51.
The Technology Services industry is part of the Business Services sector. This industry currently has a Zacks Industry Rank of 105, which puts it in the top 43% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow DUOL in the coming trading sessions, be sure to utilize Zacks.com.
NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Elastic N.V. (“Elastic” or the “Company”) (NYSE: ESTC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Elastic and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On June 24, 2026, Elastic disclosed in a filing with the U.S. Securities and Exchange Commission (“SEC”) that, in connection with “a plan . . . intended to simplify team structures, reduce organizational complexity, improve decision-making speed, reallocate resources towards key growth areas, and invest in the skills and capabilities needed to support the Company's ongoing growth”, Elastic “expects to reduce its workforce by approximately 7%.” The Company said that it “expects to incur total non-recurring cash charges of approximately $22 million to $25 million under the plan, which will primarily consist of employee-related costs, including severance and other termination benefits.” In the same press release, Elastic disclosed that “Ken Exner, the Company’s Chief Product Officer, notified the Company of his decision to resign from his position as Chief Product Officer”, effective July 17, 2026.
On this news, Elastic’s stock price fell $5.11 per share, or 8.7%, to close at $53.60 per share on June 25, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Badger Meter, Inc. (NYSE: BMI) between April 18, 2024 and April 16, 2026, inclusive (the “Class Period”), of the important August 3, 2026 lead plaintiff deadline.
SO WHAT: If you purchased Badger Meter common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Badger Meter class action, go to https://rosenlegal.com/cases/badger-meter-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 3, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made materially false and misleading statements concerning the drivers of Badger Meter’s “record” financial results, demand for Badger Meter’s products, and its prospects for continued growth. During the Class Period, defendants told investors that Badger Meter's strong financial results reflected “ongoing favorable industry trends,” “secular growth drivers,” and “solid operating execution.” They likewise touted “strong” demand and said they were seeing “robust order pacing and a strong bid pipeline that positions us well for continued sales and earnings growth,” and that Badger Meter possessed a “long runway” for growth.
According to the lawsuit, these statements were materially false and misleading. In truth, Badger Meter’s financial results during the Class Period were at least partially attributable to Badger Meter’s practice of pulling-forward customer orders to recognize revenue early, which concealed weakening demand and deteriorating near-term order trends. This practice also depleted revenue otherwise available for future periods, ultimately causing the disappointing financial results Badger Meter later reported. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Badger Meter class action, go to https://rosenlegal.com/cases/badger-meter-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827 [email protected]
www.rosenlegal.com
In the latest close session, Pilgrim's Pride (PPC - Free Report) was down 1.02% at $28.22. This change lagged the S&P 500's daily gain of 0.38%. Meanwhile, the Dow gained 0.02%, and the Nasdaq, a tech-heavy index, added 0.9%.
Shares of the poultry producer have depreciated by 1.83% over the course of the past month, underperforming the Consumer Staples sector's loss of 0.78%, and the S&P 500's gain of 1.27%.
The investment community will be paying close attention to the earnings performance of Pilgrim's Pride in its upcoming release. The company is slated to reveal its earnings on July 29, 2026. The company is expected to report EPS of $0.75, down 55.88% from the prior-year quarter. Simultaneously, our latest consensus estimate expects the revenue to be $4.9 billion, showing a 3% escalation compared to the year-ago quarter.
For the full year, the Zacks Consensus Estimates project earnings of $3.01 per share and a revenue of $18.7 billion, demonstrating changes of -41.78% and +1.09%, respectively, from the preceding year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Pilgrim's Pride. These revisions help to show the ever-changing nature of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 14.51% decrease. At present, Pilgrim's Pride boasts a Zacks Rank of #5 (Strong Sell).
Digging into valuation, Pilgrim's Pride currently has a Forward P/E ratio of 9.49. This denotes a discount relative to the industry average Forward P/E of 11.82.
The Food - Meat Products industry is part of the Consumer Staples sector. This industry, currently bearing a Zacks Industry Rank of 217, finds itself in the bottom 12% echelons of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
BETHESDA, Md.--(BUSINESS WIRE)--Walker & Dunlop released its 2026 Student Housing Outlook that signals that a strong preleasing year and resilient enrollment growth.
Sprouts Farmers (SFM - Free Report) ended the recent trading session at $75.35, demonstrating a -5.42% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of 0.38%. Elsewhere, the Dow gained 0.02%, while the tech-heavy Nasdaq added 0.9%.
The natural and organic food retailer's stock has dropped by 6.7% in the past month, falling short of the Retail-Wholesale sector's gain of 0.77% and the S&P 500's gain of 1.27%.
Market participants will be closely following the financial results of Sprouts Farmers in its upcoming release. The company plans to announce its earnings on July 29, 2026. The company is forecasted to report an EPS of $1.35, showcasing no movement from the corresponding quarter of the prior year. Our most recent consensus estimate is calling for quarterly revenue of $2.33 billion, up 4.91% from the year-ago period.
For the full year, the Zacks Consensus Estimates project earnings of $5.57 per share and a revenue of $9.51 billion, demonstrating changes of +4.9% and +8.04%, respectively, from the preceding year.
Investors should also note any recent changes to analyst estimates for Sprouts Farmers. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Sprouts Farmers is holding a Zacks Rank of #3 (Hold) right now.
Looking at its valuation, Sprouts Farmers is holding a Forward P/E ratio of 14.3. This signifies a discount in comparison to the average Forward P/E of 15.49 for its industry.
It's also important to note that SFM currently trades at a PEG ratio of 1.68. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The average PEG ratio for the Food - Natural Foods Products industry stood at 1.55 at the close of the market yesterday.
The Food - Natural Foods Products industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 107, which puts it in the top 44% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Helen of Troy (HELE) To Contact Him Directly To Discuss Their Options
If you purchased or acquired Helen of Troy common stock between April 24, 2024, and October 8, 2025 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at [email protected] or by telephone at (212) 355-4648.
Click here to participate in the action.
NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) --
What’s Happening?
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Helen of Troy Limited (“Helen of Troy” or the “Company”) (NASDAQ:HELE) in the United States District Court for the Western District of Texas on behalf of all persons and entities who purchased or otherwise acquired Helen of Troy common stock between April 24, 2024, and October 8, 2025, both dates inclusive (the “Class Period”).Investors have until August 3, 2026 to apply to the Court to be appointed as lead plaintiff in the lawsuit. What are the Allegation Details?
The Complaint alleges that throughout the Class Period, which begins shortly after Noel Geoffroy became CEO, the Company boasted about the “fuel” it was generating from Project Pegasus. The Complaint alleges that although the Company admitted to some speed bumps in Project Pegasus, specifically citing “implementation hiccups” with its new Tennessee distribution center, Defendants assured investors that “despite the delayed savings related to our Tennessee distribution center, Project Pegasus continues to move forward, we have made good progress on the cost of goods sold work streams, implementing multiple projects that reduce costs and simplify our supplier base.” The Complaint alleges that Project Pegasus was not delivering the efficiencies that Defendants touted. The Complaint continues to allege that rather, unknown to investors, Helen of Troy did not have enough resources or the budget to achieve its stated restructuring or savings goals. The Complaint further alleges that the truth began to emerge on July 9, 2024, when the Company announced its results for the first quarter of 2025, reporting that earnings per share had declined by a staggering 49% from the prior year, and reducing full-year revenue outlook by over 20%. The Complaint also alleges that the Company attributed the poor financial results to an “unusual number of internal and external challenges,” delaying the long-awaited delivery of savings from the Company’s strategic plan. The Complaint alleges that as a result of these disclosures, the price of the Company’s shares declined by $24.68 per share, or 27.7%. What are my Next Steps?
If you purchased or otherwise acquired Helen of Troy shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at [email protected], telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in securities, derivative, and commercial litigation as well as individuals in consumer protection and data privacy litigation. The firm has a nationwide practice and routinely handles cases in both federal and state courts. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Follow us for updates on LinkedIn and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn.
e.l.f. Beauty (ELF - Free Report) ended the recent trading session at $72.25, demonstrating a -3.79% change from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 0.38%. On the other hand, the Dow registered a gain of 0.02%, and the technology-centric Nasdaq increased by 0.9%.
Shares of the cosmetics company witnessed a gain of 17.36% over the previous month, beating the performance of the Consumer Staples sector with its loss of 0.78%, and the S&P 500's gain of 1.27%.
The upcoming earnings release of e.l.f. Beauty will be of great interest to investors. The company is predicted to post an EPS of $0.73, indicating a 17.98% decline compared to the equivalent quarter last year. Meanwhile, the latest consensus estimate predicts the revenue to be $424.55 million, indicating a 20.02% increase compared to the same quarter of the previous year.
For the full year, the Zacks Consensus Estimates are projecting earnings of $3.31 per share and revenue of $1.86 billion, which would represent changes of +5.75% and +13.64%, respectively, from the prior year.
Investors might also notice recent changes to analyst estimates for e.l.f Beauty. These recent revisions tend to reflect the evolving nature of short-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.25% higher. As of now, e.l.f. Beauty holds a Zacks Rank of #3 (Hold).
In the context of valuation, e.l.f. Beauty is at present trading with a Forward P/E ratio of 22.68. This indicates no noticeable deviation in contrast to its industry's Forward P/E of 22.68.
Also, we should mention that ELF has a PEG ratio of 2.14. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The average PEG ratio for the Cosmetics industry stood at 0.68 at the close of the market yesterday.
The Cosmetics industry is part of the Consumer Staples sector. Currently, this industry holds a Zacks Industry Rank of 205, positioning it in the bottom 17% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
In the latest trading session, AST SpaceMobile, Inc. (ASTS - Free Report) closed at $68.82, marking a +1.83% move from the previous day. The stock outperformed the S&P 500, which registered a daily gain of 0.38%. Elsewhere, the Dow gained 0.02%, while the tech-heavy Nasdaq added 0.9%.
The stock of company has fallen by 22.83% in the past month, lagging the Computer and Technology sector's loss of 1.5% and the S&P 500's gain of 1.27%.
Investors will be eagerly watching for the performance of AST SpaceMobile, Inc. in its upcoming earnings disclosure. The company's upcoming EPS is projected at -$0.28, signifying a 31.71% increase compared to the same quarter of the previous year. Meanwhile, the latest consensus estimate predicts the revenue to be $34.32 million, indicating a 2858.28% increase compared to the same quarter of the previous year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of -$1.47 per share and a revenue of $164.76 million, signifying shifts of -9.7% and +132.32%, respectively, from the last year.
Investors might also notice recent changes to analyst estimates for AST SpaceMobile, Inc. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Right now, AST SpaceMobile, Inc. possesses a Zacks Rank of #3 (Hold).
The Wireless Equipment industry is part of the Computer and Technology sector. This industry currently has a Zacks Industry Rank of 175, which puts it in the bottom 29% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
Nu Holdings Ltd. (NU - Free Report) closed the most recent trading day at $13.99, moving +2.34% from the previous trading session. The stock exceeded the S&P 500, which registered a gain of 0.38% for the day. At the same time, the Dow added 0.02%, and the tech-heavy Nasdaq gained 0.9%.
The stock of company has risen by 9.98% in the past month, leading the Finance sector's gain of 2.89% and the S&P 500's gain of 1.27%.
The upcoming earnings release of Nu Holdings Ltd. will be of great interest to investors. The company is predicted to post an EPS of $0.2, indicating a 42.86% growth compared to the equivalent quarter last year. Simultaneously, our latest consensus estimate expects the revenue to be $5.45 billion, showing a 48.68% escalation compared to the year-ago quarter.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $0.83 per share and a revenue of $22.42 billion, signifying shifts of +33.87% and +42.13%, respectively, from the last year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Nu Holdings Ltd. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.48% lower. Nu Holdings Ltd. currently has a Zacks Rank of #3 (Hold).
In the context of valuation, Nu Holdings Ltd. is at present trading with a Forward P/E ratio of 16.39. This expresses a premium compared to the average Forward P/E of 11.77 of its industry.
We can additionally observe that NU currently boasts a PEG ratio of 0.55. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Banks - Foreign was holding an average PEG ratio of 0.86 at yesterday's closing price.
The Banks - Foreign industry is part of the Finance sector. This group has a Zacks Industry Rank of 107, putting it in the top 44% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
MPLX LP (MPLX - Free Report) closed the most recent trading day at $56.51, moving -1.22% from the previous trading session. The stock trailed the S&P 500, which registered a daily gain of 0.38%. At the same time, the Dow added 0.02%, and the tech-heavy Nasdaq gained 0.9%.
Coming into today, shares of the company had gained 2.77% in the past month. In that same time, the Oils-Energy sector lost 1.55%, while the S&P 500 gained 1.27%.
Analysts and investors alike will be keeping a close eye on the performance of MPLX LP in its upcoming earnings disclosure. The company's earnings report is set to go public on August 4, 2026. On that day, MPLX LP is projected to report earnings of $1.08 per share, which would represent year-over-year growth of 4.85%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $3.26 billion, up 8.52% from the year-ago period.
MPLX's full-year Zacks Consensus Estimates are calling for earnings of $4.22 per share and revenue of $13.09 billion. These results would represent year-over-year changes of -12.45% and +0.71%, respectively.
Any recent changes to analyst estimates for MPLX LP should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. As of now, MPLX LP holds a Zacks Rank of #4 (Sell).
In terms of valuation, MPLX LP is presently being traded at a Forward P/E ratio of 13.56. Its industry sports an average Forward P/E of 18.85, so one might conclude that MPLX LP is trading at a discount comparatively.
One should further note that MPLX currently holds a PEG ratio of 5.49. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. As of the close of trade yesterday, the Oil and Gas - Production and Pipelines industry held an average PEG ratio of 1.88.
The Oil and Gas - Production and Pipelines industry is part of the Oils-Energy sector. This industry, currently bearing a Zacks Industry Rank of 207, finds itself in the bottom 16% echelons of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
Hims & Hers Health, Inc. (HIMS - Free Report) closed the most recent trading day at $35.15, moving +2.24% from the previous trading session. The stock outpaced the S&P 500's daily gain of 0.38%. Meanwhile, the Dow experienced a rise of 0.02%, and the technology-dominated Nasdaq saw an increase of 0.9%.
Coming into today, shares of the company had gained 13.95% in the past month. In that same time, the Medical sector gained 4.34%, while the S&P 500 gained 1.27%.
The investment community will be paying close attention to the earnings performance of Hims & Hers Health, Inc. in its upcoming release. The company is slated to reveal its earnings on August 10, 2026. The company is forecasted to report an EPS of -$0.07, showcasing a 141.18% downward movement from the corresponding quarter of the prior year. Meanwhile, our latest consensus estimate is calling for revenue of $690.21 million, up 26.68% from the prior-year quarter.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of -$0.27 per share and revenue of $2.91 billion, indicating changes of -150.94% and +23.78%, respectively, compared to the previous year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Hims & Hers Health, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 49.21% decrease. Hims & Hers Health, Inc. currently has a Zacks Rank of #3 (Hold).
Looking at its valuation, Hims & Hers Health, Inc. is holding a Forward P/E ratio of 1289.25. This expresses a premium compared to the average Forward P/E of 28.61 of its industry.
Meanwhile, HIMS's PEG ratio is currently 96.75. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. As of the close of trade yesterday, the Medical Info Systems industry held an average PEG ratio of 3.19.
The Medical Info Systems industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 100, placing it within the top 41% of over 250 industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
